Meeder Asset Management Inc Applied Genetic Technologies Corp Transaction History

Meeder Asset Management Inc

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2020 May 15, 2020	SELL	$2.36 - $9.86 $4,009 - $16,752	-1,699 Closed	0 $0
Q4 2019 Feb 13, 2020	BUY	$2.69 - $4.92 $2,340 - $4,280	870 Added 104.95%	1,699 $8,000
Q2 2019 Aug 05, 2019	BUY	$3.6 - $4.78 $676 - $898	188 Added 29.33%	829 $3,000
Q1 2019 Apr 16, 2019	BUY	$2.62 - $4.44 $639 - $1,083	244 Added 61.46%	641 $3,000
Q4 2018 Jan 17, 2019	SELL	$2.28 - $7.15 $2,305 - $7,228	-1,011 Reduced 71.8%	397 $1,000
Q3 2018 Nov 02, 2018	BUY	$3.85 - $7.35 $2,360 - $4,505	613 Added 77.11%	1,408 $0
Q3 2017 Oct 20, 2017	BUY	$3.55 - $5.25 $2,822 - $4,173	795	795 $3,000

Ticker AGTC
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 67,632,200
Description
Applied Genetic Technologies Corporation, a clinical-stage biotechnology company, develops transformational genetic therapies for patients suffering from rare and debilitating diseases. Its advanced product candidates include three ophthalmology development programs across two targets, including X-linked retinitis pigmentosa, which is in the Pha...

Get notified when there are updates to the investment portfolio of Meeder Asset Management Inc, based on Form 13F filings with the SEC.

Stay updated on Meeder Asset Management Inc with notifications on news.